search
Back to results

tDCS in Post-stroke Neglect Rehabilitation (tDCS-Neglect)

Primary Purpose

Stroke, Neglect, Hemispatial

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Transcranial direct current stimulation
Neuropsychological rehabilitation
Sponsored by
Universitat Oberta de Catalunya
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring neglect, neuropsychological rehabilitation, non-invasive brain stimulation, transcranial direct current stimulation, tDCS, stroke

Eligibility Criteria

18 Years - 89 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Hemorrhagic or ischemic stroke in the right hemisphere.
  • Stroke 3 to 12 months since the event (regardless of whether or not they have received prior rehabilitation).
  • 18 to 99 years-old.
  • Neuroimaging study.
  • Absence of previous strokes.
  • Functional capacity that allows him/her to remain seated and active for one hour (Barthel Index score greater than 5 in the item of transfers between chair and bed; this item can be scored from 0 to 15, being 0 totally dependent and 15 totally independent).
  • Right-handed manual dominance
  • Neglect scores on at least two of the three tests administered for the assessment of visuospatial neglect.
  • Signature of informed consent by the patient or his/her legal guardian.

Exclusion Criteria:

  • Dermatological problems (psoriasis, dermatitis on the scalp or face).
  • Presence of implants or metal parts in the head excluding fillings.
  • Pacemakers, medication pumps, stimulators (vagal, cerebral, transcutaneous), ventriculoperitoneal shunts or aneurysm clips.
  • Presence of previous strokes.
  • Neurological disease other than stroke described in the inclusion criteria.
  • Severe cognitive impairment assessed using the Mini-mental state examination (MMSE), excluding patients with scores under 24 (the score of MMSE are between 0 and 30, being 0 severe cognitive impairment and 30 no cognitive impairment).
  • Significant language difficulties that not allow proper understanding of activities or severely limit expression.
  • History of alcohol or drug abuse.
  • Moderate or severe active depression.
  • Uncontrolled medical problems (pathologies in acute phase without medical or pharmacological treatment with proven efficacy or pathologies with imminent life risk).
  • Pregnancy or suspected pregnancy that will be checked by pregnancy test at the beginning of the study in patients of childbearing age and with the recommendation of the use of contraceptive methods until the end of the intervention.

Sites / Locations

  • Hospital Beata María Ana (Brain Damage Unit)Recruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Sham Comparator

Other

Arm Label

Experimental group (Exp)

Sham-tDCS (Sham)

Control group (Control)

Arm Description

Active tDCS + conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation)

Sham tDCS + conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation

Conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation) without tDCS.

Outcomes

Primary Outcome Measures

Change in hemispatial neglect symptomatology
Change in hemispatial neglecteglect sympthomatology assessed by The Bell Test (Gauthier, Dehaut, and Joanette 1989)
Change in hemispatial neglect symptomatology
Change in hemispatial neglecteglect sympthomatology assessed by Copy of drawings subtest Barcelona test (Peña Casanova 2005)
Change in hemispatial neglect symptomatology
Change in hemispatial neglecteglect sympthomatology assessed by Line bisection test (Schenkenberg, Bradford, and Ajax 1980)
Change in hemispatial neglect symptomatology
Change in hemispatial neglecteglect sympthomatology assessed by The motor-free visual perception test (MVPT): (Colarusso, Hammill, and Academic Therapy Publications 1995)
Change in functional independence
Change in functional independence assessed by The Catherine Bergego Scale (Azouvi et al. 2003)
Change in functional independence
Change in functional independence assessed by Barthel Index (Mahoney and Barthel 1965)
Change in general cognitive functioning
Change in general cognitive functioning assessed by Mini-mental state examination (MMSE) (Folstein, Folstein, and McHugh 1975)
Change in neurophysiological assessment
Change in neurophysiological assessment through a resting state EEG acquisition. EEG will be recorded at rest using 64 electrodes in a system 10-20 distribution. An actiCHamp amplifier (Brain Vision LLC, North Carolina, United States) will be used to amplify and digitize the EEG data at a sampling frequency of 512 Hz. Alpha, Beta, Theta and Gamma bands will be recorded.

Secondary Outcome Measures

Side effects and patient comfort assessment
Assessment of the presence or not of side effects and comport or discomfort of the patient during the intervention

Full Information

First Posted
November 12, 2019
Last Updated
November 8, 2022
Sponsor
Universitat Oberta de Catalunya
Collaborators
Hospital Beata María Ana, Universidad Francisco de Vitoria
search

1. Study Identification

Unique Protocol Identification Number
NCT04458974
Brief Title
tDCS in Post-stroke Neglect Rehabilitation
Acronym
tDCS-Neglect
Official Title
Transcranial Direct Current Stimulation as Coadjuvant Intervention in Post-stroke Neglect Rehabilitation
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 8, 2019 (Actual)
Primary Completion Date
November 2023 (Anticipated)
Study Completion Date
November 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitat Oberta de Catalunya
Collaborators
Hospital Beata María Ana, Universidad Francisco de Vitoria

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Introduction Stroke is the main cause of disability in the world and its sequelae have a great impact in the functional independence and quality of life of patients and families. Unilateral spatial neglect is one of the most frequent cognitive deficits after stroke, and its maintenance is associated with poor functional outcome of the rehabilitation process. For many years clinical research has been conducted to develop new and effective rehabilitation strategies for neglect. Noninvasive brain stimulation (NIBS) techniques are important tools in this regard, and it should be considered as a therapeutic intervention used in combination with conventional neuropsychological approaches. Transcranial direct current stimulation (tDCS) is a noninvasive, safe, neurophysiological technique able to modulate cortical activity by inducing a weak electric current into the brain. The studies focused on neglect symptoms treatment by means of tDCS over the lesional and contralesional hemisphere have shown promising results and its combination with conventional neglect therapies may enhance treatment efficacy and speed the recovery. Objectives To improve neglect symptoms by reducing the pathological hyperactivity of the undamaged hemisphere after right medial cerebral artery stroke, through the application of multisite tDCS, and to validate a NIBS protocol for the enhancement of conventional neuropsychological rehabilitation outcome. Methods The sample will be composed by 30 patients with spatial neglect secondary to a ischemic stroke in the middle cerebral artery in subacute stage (3 to 12 months since the event). The patients will be randomly assigned to one experimental group (Active, Sham, and Control). The intervention protocol consists in a two weeks intervention (10 sessions, 45 min, Monday to Friday) of tDCS and neuropsychological rehabilitation applied concurrently. In each session a 20 min tDCS at 2 milliamps (m will be applied over P3 according to 10/20 EEG international system (cathodal) with return electrodes placed in C3,CP5,CP1,Pz,PO3,PO7,P7 (10/20 EEG). StarStim® tDCS 8 channels Multisite device will be used.
Detailed Description
Transcranial direct current stimulation (tDCS) is a safe and non-invasive neurophysiological technique with enough scientific literature that supports its effectiveness and safety, both in healthy subjects and in different neurological pathologies. However, it has not been consolidated yet as a real clinical alternative for other pathologies different from depression, due to the impossibility of establishing specific intervention protocols given the heterogeneity of the samples and the methods of assessment of the results used in the different studies. Regarding stroke, although there is large empirical evidence of its effectiveness in motor rehabilitation, there are few studies to date focused on cognitive rehabilitation, such neglect rehabilitation. Hypothesis The main hypothesis is that patients who receive a treatment based on tDCS in combination with conventional neuropsychological intervention for the recovery of neglect will have a greater improvement in neglect symptomatology in comparison to patients who receive the conventional treatment in isolation. Objectives The main objective of the project is to validate a protocol for the enhancement of conventional neuropsychological rehabilitation using tDCS in a group of patients with spatial neglect secondary to a cortical ischemic stroke in the middle cerebral artery (MCA) in a subacute phase (3 to 12 months since the event). Specific objectives: To demonstrate that non-invasive neuromodulation by means of tDCS enhances the efficacy of the conventional neuropsychological rehabilitation. Identify clinical and neurophysiological variables of the patients are the best predictors of the efficacy of the combined treatment. To verify the greater impact of the combined treatment in the improvement of the symptomatology of neglect as well as in the patient's quality of life in comparison with the conventional intervention. Methods Design: The present study is a parallel, randomized, controlled and triple blind experimental study. The patients included in the sample will be randomly distributed into three groups (Exp, Sham and Control) that will be blind to the patients, to the researchers who apply the tDCS and to the pre and post intervention evaluators. Experimental group (Exp): active tDCS + conventional neuropsychological rehabilitation. Control group placebo-tDCS (Sham): placebo tDCS (sham) + conventional neuropsychological rehabilitation. Control group (Control): conventional neuropsychological rehabilitation without tDCS. The duration of the study will be 3 years. Sample: The sample will consist of 30 volunteer patients randomly distributed to one of the experimental condition (1:1:1) with blind of the randomization sequence. Randomization will be done with the help of the research support department of the Francisco de Vitoria University. Patients will be recruited in the Brain Damage Unit of Beata María Ana Hospital by the unit neurologist and neuropsychologists among those patients who meet the inclusion criteria.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Neglect, Hemispatial
Keywords
neglect, neuropsychological rehabilitation, non-invasive brain stimulation, transcranial direct current stimulation, tDCS, stroke

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Parallel, randomized, controlled and triple blind experimental study
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental group (Exp)
Arm Type
Experimental
Arm Description
Active tDCS + conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation)
Arm Title
Sham-tDCS (Sham)
Arm Type
Sham Comparator
Arm Description
Sham tDCS + conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation
Arm Title
Control group (Control)
Arm Type
Other
Arm Description
Conventional rehabilitation therapy (physiotherapy and neuropsychological rehabilitation) without tDCS.
Intervention Type
Device
Intervention Name(s)
Transcranial direct current stimulation
Intervention Description
The intervention consists in two-weeks treatment, 10 consecutive sessions of tDCS ( Monday to Friday) applied concurrently to neuropsychological rehabilitation. The tDCS Multisite StratStim® 8-channel device (Neuroelectrics) will be used for tDCS stimulation. The duration of the stimulation will be 20 minutes at 2 mA. The tDCS will be applied with the cathode positioned in P3 (following the international 10/20 EEG system), and the return electrodes will be placed in C3, CP5, CP1, Pz, PO3, PO7, P7. The sessions will last 1 hour.
Intervention Type
Procedure
Intervention Name(s)
Neuropsychological rehabilitation
Intervention Description
The neuropsychological rehabilitation protocol has been designed for the recovery of neglect symptomatology. Each session will consist on the performance of different cognitive stimulation tasks aimed at improving attention and visoperceptive abilities. The tasks will be applied through the NeuronUp neurorehabilitation platform in order to achieve maximum homogeneity and objectivity across patients. The neuropsychological rehabilitation will last 30min (in 1h intervention session).
Primary Outcome Measure Information:
Title
Change in hemispatial neglect symptomatology
Description
Change in hemispatial neglecteglect sympthomatology assessed by The Bell Test (Gauthier, Dehaut, and Joanette 1989)
Time Frame
Pre and post intervention (3 days after the end of intervention)
Title
Change in hemispatial neglect symptomatology
Description
Change in hemispatial neglecteglect sympthomatology assessed by Copy of drawings subtest Barcelona test (Peña Casanova 2005)
Time Frame
Pre and post intervention (3 days after the end of intervention)
Title
Change in hemispatial neglect symptomatology
Description
Change in hemispatial neglecteglect sympthomatology assessed by Line bisection test (Schenkenberg, Bradford, and Ajax 1980)
Time Frame
Pre and post intervention (3 days after the end of intervention)
Title
Change in hemispatial neglect symptomatology
Description
Change in hemispatial neglecteglect sympthomatology assessed by The motor-free visual perception test (MVPT): (Colarusso, Hammill, and Academic Therapy Publications 1995)
Time Frame
Pre and post intervention (3 days after the end of intervention)
Title
Change in functional independence
Description
Change in functional independence assessed by The Catherine Bergego Scale (Azouvi et al. 2003)
Time Frame
Pre and post intervention (3 days after the end of intervention)
Title
Change in functional independence
Description
Change in functional independence assessed by Barthel Index (Mahoney and Barthel 1965)
Time Frame
Pre and post intervention (3 days after the end of intervention)
Title
Change in general cognitive functioning
Description
Change in general cognitive functioning assessed by Mini-mental state examination (MMSE) (Folstein, Folstein, and McHugh 1975)
Time Frame
Pre and post intervention (3 days after the end of intervention)
Title
Change in neurophysiological assessment
Description
Change in neurophysiological assessment through a resting state EEG acquisition. EEG will be recorded at rest using 64 electrodes in a system 10-20 distribution. An actiCHamp amplifier (Brain Vision LLC, North Carolina, United States) will be used to amplify and digitize the EEG data at a sampling frequency of 512 Hz. Alpha, Beta, Theta and Gamma bands will be recorded.
Time Frame
Pre and post intervention (3 days after the end of intervention)
Secondary Outcome Measure Information:
Title
Side effects and patient comfort assessment
Description
Assessment of the presence or not of side effects and comport or discomfort of the patient during the intervention
Time Frame
Pre and post session (before and at the end of every session - 1 min after the end of the session)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Hemorrhagic or ischemic stroke in the right hemisphere. Stroke 3 to 12 months since the event (regardless of whether or not they have received prior rehabilitation). 18 to 99 years-old. Neuroimaging study. Absence of previous strokes. Functional capacity that allows him/her to remain seated and active for one hour (Barthel Index score greater than 5 in the item of transfers between chair and bed; this item can be scored from 0 to 15, being 0 totally dependent and 15 totally independent). Right-handed manual dominance Neglect scores on at least two of the three tests administered for the assessment of visuospatial neglect. Signature of informed consent by the patient or his/her legal guardian. Exclusion Criteria: Dermatological problems (psoriasis, dermatitis on the scalp or face). Presence of implants or metal parts in the head excluding fillings. Pacemakers, medication pumps, stimulators (vagal, cerebral, transcutaneous), ventriculoperitoneal shunts or aneurysm clips. Presence of previous strokes. Neurological disease other than stroke described in the inclusion criteria. Severe cognitive impairment assessed using the Mini-mental state examination (MMSE), excluding patients with scores under 24 (the score of MMSE are between 0 and 30, being 0 severe cognitive impairment and 30 no cognitive impairment). Significant language difficulties that not allow proper understanding of activities or severely limit expression. History of alcohol or drug abuse. Moderate or severe active depression. Uncontrolled medical problems (pathologies in acute phase without medical or pharmacological treatment with proven efficacy or pathologies with imminent life risk). Pregnancy or suspected pregnancy that will be checked by pregnancy test at the beginning of the study in patients of childbearing age and with the recommendation of the use of contraceptive methods until the end of the intervention.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Elena M Marron, PhD
Phone
+34620912976
Email
emunozmarr@uoc.edu
Facility Information:
Facility Name
Hospital Beata María Ana (Brain Damage Unit)
City
Madrid
ZIP/Postal Code
28007
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Juan Pablo Romero, MD, PhD
Phone
+34914090903
Email
p.romero.prof@ufv.es

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

tDCS in Post-stroke Neglect Rehabilitation

We'll reach out to this number within 24 hrs